RMP predicts survival and adjuvant TACE response in hepatocellular carcinoma

Adjuvant transcatheter arterial chemoembolization (TACE) protects against hepatocellular carcinoma (HCC) and is associated with reduced disease recurrence and improved outcome after surgery. However, deterioration of liver function after TACE negatively impacts the patient prognosis and limits it us...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Zhang, Jian, Jiang, Tian-Yi, Jiang, Bei-Ge, Yang, Chun, Tan, Ye-Xiong, Yang, Ning, Pan, Yu-Fei, Ding, Zhi-Wen, Yang, Guang-Zhen, Wu, Meng-Chao, Dong, Li-Wei, Wang, Hong-Yang
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2014
Teme:
Clinical Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4413664/
https://ncbi.nlm.nih.gov/pubmed/25605019
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki